InsidersTradesSigma
Instil Bio, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)
Track the Instil Bio, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, Instil Bio, Inc. has published 1 insider filings. Market capitalisation: €54.5m. The latest transaction was disclosed on 17 March 2022 (J). Among the most active insiders: McGaughy R Kent Jr. All data is openly available.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Instil Bio, Inc. Hold (neutral), based on 1 analysts. Average price target: US$7.00.
12Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 17 March 2022
Declarations1 total
260,323 shares0Common StockSEC:0001567619-22-007150:0
1 of 1 declaration